Opportunity Information: Apply for RFA DC 12 003
Apply for RFA DC 12 003
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCD Research On Hearing Health Care (R21/R33)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders.
- This funding opportunity was created on May 19, 2011 and posted on May 19, 2011.
- Applicants must submit their applications by Feb 28, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $275,000.00 in funding.
- Eligible applicants include: Native American tribal governments (Federally recognized) Small businesses Special district governments Independent school districts State governments City or township governments Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign (non U.S.) components of U.S. Organizations are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIDCD Research On Hearing Health Care (R21/R33) opportunity (Funding Opportunity Number RFA-DC-12-003) is a National Institutes of Health discretionary grant designed to move practical, real-world hearing health care solutions from early exploration into more mature development and testing. It targets research and related infrastructure that can make hearing health care more accessible and more affordable, with an emphasis on approaches that can actually be delivered at scale to the people who need them and that improve health care access and outcomes. Within the scope of this program, "hearing health care" is defined broadly but with a clear focus: assessment and screening for hearing loss, and nonmedical treatment and rehabilitation. That includes hearing aid selection and fitting as well as aural rehabilitation activities such as counseling and auditory training. The announcement also explicitly welcomes outcomes research and health services research, meaning studies that look at what works in real settings, how care is delivered, what barriers exist, and how changes in systems or models of care affect results for patients and communities.
The grant uses the NIH Exploratory/Developmental Phased Innovation mechanism, which is structured as a two-stage project with a built-in pathway to expansion. The first stage is the R21 phase, which can last up to two years and is intended for preliminary work, pilot studies, proof-of-concept testing, early development, and other foundational activities needed to demonstrate feasibility and justify a larger effort. A key requirement is that applicants propose measurable R21 milestones, so the early phase is not open-ended; it must produce specific, trackable outputs that can be used to judge readiness to move forward. If those milestones are met and the project shows sufficient progress, the award can transition to the R33 phase, which can provide up to four additional years of support for expanded research and development. Even though the R33 can extend up to four years, the total project period under this FOA cannot exceed five years, so applicants need to design a plan that fits within that overall timeline.
In practical terms, this program is aimed at innovations that lower cost, remove access barriers, and improve the delivery and effectiveness of hearing-related services outside of strictly medical interventions. Projects could involve new screening or assessment workflows, new models for fitting and supporting hearing aid use, improved counseling or auditory training approaches, or system-level strategies that make it easier for individuals and communities to obtain and benefit from hearing care. Because outcomes and health services research are considered responsive, proposals can also focus on evaluating and improving real-world service delivery, such as examining access gaps, testing alternative care pathways, measuring patient-centered outcomes, or analyzing how affordability and availability affect uptake and long-term benefit.
Administrative details from the posting indicate this is a grant in the health category under CFDA 93.173 (Research Related to Deafness and Communication Disorders), with no cost sharing or matching requirement. The posting date was May 19, 2011, with an original and current closing date of February 28, 2013, and an archive date of March 31, 2013. The opportunity listed an estimated total funding amount of $500,000 and an award ceiling of $275,000. Eligibility is broad and includes many types of applicants across government, academic, nonprofit, and private sectors. Examples include state, county, city/township, and special district governments; federally recognized tribal governments and other tribal organizations; public and private institutions of higher education (including HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities); nonprofits with or without 501(c)(3) status (with the noted higher-education exception); for-profit organizations (including small businesses); independent school districts; public housing authorities/Indian housing authorities; faith-based and community-based organizations; eligible federal agencies; regional organizations; and non-U.S. entities, including foreign organizations and foreign components of U.S. organizations. The full announcement and details were made available through the NIH Grants Guide at the link provided in the source material.
Frequently Asked Questions (FAQs)
What is the NIDCD Research On Hearing Health Care (R21/R33) funding opportunity?
This opportunity (Funding Opportunity Number RFA-DC-12-003) is an NIH discretionary grant from NIDCD designed to move practical, real-world hearing health care solutions from early exploration into more mature development and testing, with an emphasis on approaches that can be delivered at scale.
What is the main goal of this program?
The program aims to support research and related infrastructure that make hearing health care more accessible and more affordable, while improving health care access and outcomes in real-world settings.
How does this FOA define "hearing health care"?
Within this program, "hearing health care" is defined broadly but with a clear focus on assessment and screening for hearing loss, and nonmedical treatment and rehabilitation. This includes hearing aid selection and fitting, and aural rehabilitation activities such as counseling and auditory training.
Are medical or surgical interventions included in the scope?
The described scope emphasizes nonmedical treatment and rehabilitation (for example, hearing aid selection and fitting, counseling, and auditory training), along with assessment and screening. The focus is not on strictly medical interventions.
What types of research are explicitly welcomed?
The announcement explicitly welcomes outcomes research and health services research, including studies that examine what works in real settings, how care is delivered, what barriers exist, and how changes in systems or models of care affect patient and community outcomes.
What are examples of responsive project areas?
Examples described as within scope include new screening or assessment workflows, new models for fitting and supporting hearing aid use, improved counseling or auditory training approaches, and system-level strategies that make it easier for individuals and communities to obtain and benefit from hearing care.
Can projects focus on real-world service delivery and access barriers?
Yes. Because outcomes and health services research are responsive, projects can focus on evaluating and improving real-world service delivery, including examining access gaps, testing alternative care pathways, measuring patient-centered outcomes, and analyzing how affordability and availability affect uptake and long-term benefit.
What grant mechanism does this opportunity use?
It uses the NIH Exploratory/Developmental Phased Innovation mechanism (R21/R33), which is a two-stage project structure with a built-in pathway to expand the work if early milestones are achieved.
How long can the R21 phase last, and what is it intended to support?
The R21 phase can last up to two years and is intended for preliminary work such as pilot studies, proof-of-concept testing, early development, and other foundational activities needed to demonstrate feasibility and justify a larger effort.
Are milestones required for the R21 phase?
Yes. A key requirement is that applicants propose measurable R21 milestones so the early phase produces specific, trackable outputs that can be used to judge readiness to transition to the R33 phase.
What is the R33 phase, and how long can it last?
If the R21 milestones are met and the project demonstrates sufficient progress, the award can transition to the R33 phase, which can provide up to four additional years of support for expanded research and development.
What is the maximum total project period under this FOA?
The total project period under this funding opportunity cannot exceed five years, so the R21 and R33 phases together must fit within that overall timeline.
Does the FOA require cost sharing or matching funds?
No. The posting indicates there is no cost sharing or matching requirement.
What is the CFDA number and program area for this opportunity?
The opportunity is listed under CFDA 93.173, Research Related to Deafness and Communication Disorders.
How much funding is available, and what is the award ceiling?
The posting lists an estimated total funding amount of $500,000 and an award ceiling of $275,000.
Who is eligible to apply?
Eligibility is broad and includes many applicant types across government, academic, nonprofit, and private sectors. Examples listed include state, county, city/township, and special district governments; federally recognized tribal governments and other tribal organizations; public and private institutions of higher education (including HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities); nonprofits with or without 501(c)(3) status (with the noted higher-education exception); for-profit organizations (including small businesses); independent school districts; public housing authorities/Indian housing authorities; faith-based and community-based organizations; eligible federal agencies; regional organizations; and non-U.S. entities, including foreign organizations and foreign components of U.S. organizations.
Are non-U.S. organizations eligible?
Yes. The eligibility list includes non-U.S. entities, including foreign organizations and foreign components of U.S. organizations.
What kinds of institutions of higher education are included as eligible?
The eligibility description includes public and private institutions of higher education and specifically notes categories such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities.
What is the posting date and closing date for this opportunity?
The posting date was May 19, 2011. The original and current closing date listed is February 28, 2013.
When was the opportunity archived?
The archive date listed is March 31, 2013.
Where were the full announcement and details made available?
The full announcement and details were made available through the NIH Grants Guide at the link provided in the source material.
What is the overall emphasis in terms of impact and scalability?
The emphasis is on approaches that lower cost, remove access barriers, improve delivery and effectiveness of hearing-related services, and can be delivered at scale to the people who need them.
Does this program support infrastructure related to hearing health care research?
Yes. The description states it targets research and related infrastructure that can make hearing health care more accessible and affordable and improve access and outcomes.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Craniofacial Malformations Information for Affected Families, Health Care Providers, and School Professionals
Previous opportunity: Volunteer Income Tax Assistance (VITA) Grant
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DC 12 003
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DC 12 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Craniofacial Malformations Information for Affected Families, Health Care Providers, and School Professionals Apply for CDC RFA DD11 1105 Funding Number: CDC RFA DD11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Addressing Immunization Disparities in Minority Populations Apply for CDC RFA IP11 1101 Funding Number: CDC RFA IP11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Capacity Building Assistance (CBA) To Improve The Delivery And Effectiveness Of Human Immunodeficiency Virus (HIV) Prevention Services For High Risk And/Or Racial/Ethnic Minority Populations Apply for CDC RFA PS09 9060201SUPP11 Funding Number: CDC RFA PS09 9060201SUPP11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $103,550 |
| Systems for Improved Access to Pharmaceuticals and Services Apply for SOL OAA 11 000064 Funding Number: SOL OAA 11 000064 Agency: Agency for International Development Category: Health Funding Amount: $198,000,000 |
| FY11 OAH National Resource Center for HIV/AIDS Prevention among Adolescents Apply for AH TP2 11 001 Funding Number: AH TP2 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $200,000 |
| Technology Development for High Throughput Functional Genomics (R21) Apply for RFA HG 11 014 Funding Number: RFA HG 11 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for High Throughput Functional Genomics (R01) Apply for RFA HG 11 013 Funding Number: RFA HG 11 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for High Throughput Functional Genomics (R43/44) Apply for RFA HG 11 015 Funding Number: RFA HG 11 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| ORAL HEALTH TRAINING AND TECHNICAL ASSISTANCE NATIONAL COOPERATIVE AGREEMENT Apply for HRSA 11 180 Funding Number: HRSA 11 180 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Mechanistic Studies of HIV exposed Seronegative Individuals (HESN)(R21) Apply for PA 11 217 Funding Number: PA 11 217 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mechanistic Studies of HIV exposed Seronegative Individuals (HESN) (R01) Apply for PA 11 218 Funding Number: PA 11 218 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Predictive Biodosimetry Discovery and Development of Biomarkers for Acute and Delayed Radiation Injuries (R01) Apply for RFA AI 11 033 Funding Number: RFA AI 11 033 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| FY11 Campus Men Supporting Womens Health Project (CMSWHP) Apply for WH HPP 11 001 Funding Number: WH HPP 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $240,000 |
| FY11 Health Care Provider Response to Violence Against Women Education, Training and Technical Assistance Program Apply for WH AST 11 001 Funding Number: WH AST 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,600,000 |
| FY11 Faith Advocates for Health Relationships Training and Technical Assistance Project Apply for WH AST 11 002 Funding Number: WH AST 11 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 11 219 Funding Number: PAR 11 219 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01) Apply for RFA AI 11 036 Funding Number: RFA AI 11 036 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Limited Competition NIMHD Endowment Program for Increasing Research and Institutional Resources Capacity (S21) Apply for RFA MD 11 006 Funding Number: RFA MD 11 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Therapeutics for Neurotropic Biodefense Toxins and Pathogens (R21/R33) Apply for RFA AI 11 027 Funding Number: RFA AI 11 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY11 Announcement of Availability of Funds for Phase II of the Coalition for a Healthier Community Program Apply for WH CCE 11 001 Funding Number: WH CCE 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DC 12 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.